Search
for
Sort by
Research 301–330 of 1000+
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- ROR2 regulates self-renewal and maintenance of hair follicle stem cells
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Skin diseases in consequence of endocrine alterations
- Specific inhibition of FGF5-induced cell proliferation by RNA aptamers
- Comparative Proteomic Analysis in Scar-Free Skin Regeneration in Acomys cahirinus and Scarring Mus musculus
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Different Requirements for GFRα2-Signaling in Three Populations of Cutaneous Sensory Neurons
- Analysis of the relationship between the mutation site of the SLC39A4 gene and acrodermatitis enteropathica by reporting a rare Chinese twin: a case report and review of the literature
- A newly discovered linkage between proteoglycans and hair biology: decorin acts as an anagen inducer
- Antisense oligonucleotide targeting fibroblast growth factor receptor (FGFR)-1 stimulates cellular activity of hair follicles in an<i>in vitro</i>organ culture system
- TREMendous Macrophages Inhibit Hair Growth
- Effects of adenosine triphosphate on vandetanib induced skin damage in rats
- The urine as a diagnostic key for a homozygous EGFR mutation
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Role of Metformin in Acanthosis Nigricans
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- 皮膚組織の再生に向けた皮膚由来幹細胞に関する研究